Literature DB >> 15272002

Diphtheria toxin-induced autophagic cardiomyocyte death plays a pathogenic role in mouse model of heart failure.

Hiroshi Akazawa1, Shinji Komazaki, Hiroaki Shimomura, Fumio Terasaki, Yunzeng Zou, Hiroyuki Takano, Toshio Nagai, Issei Komuro.   

Abstract

It is still not clear whether loss of cardiomyocytes through programmed cell death causes heart failure. To clarify the role of cell death in heart failure, we generated transgenic mice (TG) that express human diphtheria toxin receptor in the hearts. A mosaic expression pattern of the transgene was observed, and the transgene-expressing cardiomyocytes (17.3% of the total cardiomyocytes) were diffusely scattered throughout the ventricles. Intramuscular injection of diphtheria toxin induced complete elimination of the transgene-expressing cardiomyocytes within 7 days, and approximately 80% of TG showed pathophysiological features characteristic of heart failure and were dead within 14 days. Degenerated cardiomyocytes of the TG heart showed characteristic features indicative of autophagic cell death such as up-regulated lysosomal markers and abundant autophagosomes containing cytosolic organelles like cardiomyocytes of human dilated cardiomyopathy. The heart failure-inducible TG are a useful model for dilated cardiomyopathy, and provided evidence indicating that myocardial cell loss through autophagic cell death plays of a causal role in the pathogenesis heart failure. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272002     DOI: 10.1074/jbc.M313084200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Zebrafish cardiac injury and regeneration models: a noninvasive and invasive in vivo model of cardiac regeneration.

Authors:  Michael S Dickover; Ruilin Zhang; Peidong Han; Neil C Chi
Journal:  Methods Mol Biol       Date:  2013

Review 2.  Autophagy in cell death: an innocent convict?

Authors:  Beth Levine; Junying Yuan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 3.  Therapeutic targeting of autophagy in disease: biology and pharmacology.

Authors:  Yan Cheng; Xingcong Ren; William N Hait; Jin-Ming Yang
Journal:  Pharmacol Rev       Date:  2013-08-13       Impact factor: 25.468

4.  Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes.

Authors:  Xianmin Xu; Satoru Kobayashi; Kai Chen; Derek Timm; Paul Volden; Yuan Huang; James Gulick; Zhenyu Yue; Jeffrey Robbins; Paul N Epstein; Qiangrong Liang
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

5.  Layer V cortical neurons require microglial support for survival during postnatal development.

Authors:  Masaki Ueno; Yuki Fujita; Tatsuhide Tanaka; Yuka Nakamura; Junichi Kikuta; Masaru Ishii; Toshihide Yamashita
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

Review 6.  Role of autophagy in heart failure associated with aging.

Authors:  Guido R Y De Meyer; Gilles W De Keulenaer; Wim Martinet
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

7.  Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.

Authors:  Xianmin Xu; Kai Chen; Satoru Kobayashi; Derek Timm; Qiangrong Liang
Journal:  J Pharmacol Exp Ther       Date:  2011-12-30       Impact factor: 4.030

8.  Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.

Authors:  Satoru Kobayashi; Paul Volden; Derek Timm; Kai Mao; Xianmin Xu; Qiangrong Liang
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

9.  Immunohistochemical analysis of macroautophagy: recommendations and limitations.

Authors:  Wim Martinet; Dorien M Schrijvers; Jean-Pierre Timmermans; Hidde Bult; Guido R Y De Meyer
Journal:  Autophagy       Date:  2012-12-14       Impact factor: 16.016

Review 10.  The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.

Authors:  Huabo Su; Xuejun Wang
Journal:  Cardiovasc Res       Date:  2009-08-20       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.